Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2025-12-24 @ 5:25 PM
NCT ID:
NCT02734550
Eligibility Criteria:
Inclusion Criteria:
* Severe sepsis or septic shock
* Onset of sepsis no longer than 24 hours
* Increased risk of invasive candida infection with at least one of the following criteria:
* total parenteral nutrition ≥48 hours
* abdominal surgery within the last 7 days
* antimicrobial therapy for at least 48 hours within the last 7 days
* Acute or chronic renal failure with renal replacement therapy
* Age ≥18 years
* Informed consent of the patient or legal representative or delayed consent process is started if patient is incapable of giving informed consent and no legal representative is available.
Exclusion Criteria:
* Pregnant or lactating women
* Ongoing invasive candida infection
* systemic antifungal therapy
* liver cirrhosis Child C
* cardiopulmonary bypass within the last 4 weeks
* treatment with immunoglobulins within the last 14 days
* immunosuppression (solid organ transplantation, AISA, leukopenia)
* participation in another intervention study
* no commitment to full therapy (i.e. DNR order)
* Infauste Prognose aufgrund von Nebenerkrankungen
* kin to or colleague of study personnel
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02734550
Study Brief:
Protocol Section:
NCT02734550